Follicle-stimulating hormone/luteinising hormone chimera

Drug Profile

Follicle-stimulating hormone/luteinising hormone chimera

Alternative Names: FSH-LH chimera

Latest Information Update: 09 May 2005

Price : $50

At a glance

  • Originator Merck Serono
  • Class Follicle stimulating hormones; Pituitary gonadotropins; Recombinant fusion proteins
  • Mechanism of Action Ovarian follicle stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Discontinued Female infertility

Most Recent Events

  • 31 Dec 2004 Discontinued - Preclinical for Female infertility in Switzerland (unspecified route)
  • 09 Sep 2003 Preclinical trials in Female infertility in Switzerland (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top